Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · enVVeno Medical Corp (NVNO)

enVVeno Medical regains Nasdaq compliance; reports about $28 million in cash

Neutral Impact 3 of 5 legal/regulatory Written later

enVVeno Medical said Nasdaq notified it that the company regained compliance with the $1.00 minimum bid price rule and that the matter is closed. The company also reported cash and investments of approximately $28 million as of December 31, 2025. The filing does not include revenue, net loss, or guidance, and the company says it expects to share more details on its 2026 strategic plans in the coming weeks.

Key points

  • Nasdaq confirmed the closing bid price was at or above $1.00 for 10 consecutive business days, from January 20, 2026 through February 2, 2026.
  • Cash and investments were approximately $28 million as of December 31, 2025.
  • The company expects to share additional details on its 2026 strategic plans in the coming weeks.

The filing

CompanyenVVeno Medical Corp (NVNO)
Form8-K, current report
Filed with the SECFeb 4, 2026, 8:30 AM ET
Accession number0001493152-26-005030

Items reported: 2.02 Results of Operations8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:53 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 04, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.